BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12960017)

  • 1. Molecular basis for the substrate selectivity of cat type I iodothyronine deiodinase.
    Kuiper GG; Wassen F; Klootwijk W; Van Toor H; Kaptein E; Visser TJ
    Endocrinology; 2003 Dec; 144(12):5411-21. PubMed ID: 12960017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships for thyroid hormone deiodination by mammalian type I iodothyronine deiodinases.
    Toyoda N; Kaptein E; Berry MJ; Harney JW; Larsen PR; Visser TJ
    Endocrinology; 1997 Jan; 138(1):213-9. PubMed ID: 8977406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodothyronine deiodinase activities in FRTL5 cells: predominance of type I 5'-deiodinase.
    Borges M; Ingbar SH; Silva JE
    Endocrinology; 1990 Jun; 126(6):3059-68. PubMed ID: 2351108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the active site cysteine in catalysis by type 1 iodothyronine deiodinase.
    Sun BC; Harney JW; Berry MJ; Larsen PR
    Endocrinology; 1997 Dec; 138(12):5452-8. PubMed ID: 9389531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and selective inner ring deiodination of thyroxine sulfate by rat liver deiodinase.
    Mol JA; Visser TJ
    Endocrinology; 1985 Jul; 117(1):8-12. PubMed ID: 4006868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and in vitro expression of the human selenoprotein, type I iodothyronine deiodinase.
    Mandel SJ; Berry MJ; Kieffer JD; Harney JW; Warne RL; Larsen PR
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1133-9. PubMed ID: 1400883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deiodination of thyroid hormone by human liver.
    Visser TJ; Kaptein E; Terpstra OT; Krenning EP
    J Clin Endocrinol Metab; 1988 Jul; 67(1):17-24. PubMed ID: 3379132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of recombinant membrane-bound type I iodothyronine deiodinase in yeast.
    Kuiper GG; Klootwijk W; Visser TJ
    J Mol Endocrinol; 2005 Jun; 34(3):865-78. PubMed ID: 15956354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deiodination of iodothyronine sulfamates by type I iodothyronine deiodinase of rat liver.
    Rutgers M; Heusdens FA; Visser TJ
    Endocrinology; 1991 Sep; 129(3):1375-81. PubMed ID: 1874177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of critical amino acids for 3,5,3'-triiodothyronine deiodination by human type 1 deiodinase based on comparative functional-structural analyses of the human, dog, and rat enzymes.
    Toyoda N; Harney JW; Berry MJ; Larsen PR
    J Biol Chem; 1994 Aug; 269(32):20329-34. PubMed ID: 8051127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenolic and tyrosyl ring iodothyronine deiodination and thyroid hormone concentrations in the human central nervous system.
    Campos-Barros A; Hoell T; Musa A; Sampaolo S; Stoltenburg G; Pinna G; Eravci M; Meinhold H; Baumgartner A
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2179-85. PubMed ID: 8964848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and inactivation of thyroid hormone by type I iodothyronine deiodinase.
    Moreno M; Berry MJ; Horst C; Thoma R; Goglia F; Harney JW; Larsen PR; Visser TJ
    FEBS Lett; 1994 May; 344(2-3):143-6. PubMed ID: 8187873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of chicken hepatic type I and type III iodothyronine deiodinases during embryonic development.
    Van der Geyten S; Sanders JP; Kaptein E; Darras VM; Kühn ER; Leonard JL; Visser TJ
    Endocrinology; 1997 Dec; 138(12):5144-52. PubMed ID: 9389494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ascidian homolog of vertebrate iodothyronine deiodinases.
    Shepherdley CA; Klootwijk W; Makabe KW; Visser TJ; Kuiper GG
    Endocrinology; 2004 Mar; 145(3):1255-68. PubMed ID: 14657009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of recombinant Xenopus laevis type I iodothyronine deiodinase: substitution of a proline residue in the catalytic center by serine (Pro132Ser) restores sensitivity to 6-propyl-2-thiouracil.
    Kuiper GG; Klootwijk W; Morvan Dubois G; Destree O; Darras VM; Van der Geyten S; Demeneix B; Visser TJ
    Endocrinology; 2006 Jul; 147(7):3519-29. PubMed ID: 16601143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a propylthiouracil-insensitive type I iodothyronine deiodinase.
    Sanders JP; Van der Geyten S; Kaptein E; Darras VM; Kühn ER; Leonard JL; Visser TJ
    Endocrinology; 1997 Dec; 138(12):5153-60. PubMed ID: 9389495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of type III iodothyronine deiodinase from the fish Oreochromis niloticus.
    Sanders JP; Van der Geyten S; Kaptein E; Darras VM; Kühn ER; Leonard JL; Visser TJ
    Endocrinology; 1999 Aug; 140(8):3666-73. PubMed ID: 10433225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outer and inner ring monodeiodination of thyroxine by dog thyroid and liver: a comparative study using a particulate cell fraction.
    Laurberg P; Boye N
    Endocrinology; 1982 Jun; 110(6):2124-30. PubMed ID: 7075551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential deiodination of thyroxine in human thyroid gland.
    Ishii H; Inada M; Tanaka K; Mashio Y; Naito K; Nishikawa M; Matsuzuka F; Kuma K; Imura H
    J Clin Endocrinol Metab; 1982 Nov; 55(5):890-6. PubMed ID: 6896880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate-induced down-regulation of human type 2 deiodinase (hD2) is mediated through proteasomal degradation and requires interaction with the enzyme's active center.
    Steinsapir J; Bianco AC; Buettner C; Harney J; Larsen PR
    Endocrinology; 2000 Mar; 141(3):1127-35. PubMed ID: 10698189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.